Table 1 Participant characteristics.
From: Post-COVID-19 patients suffer from chemosensory, trigeminal, and salivary dysfunctions
Post-COVID-19 patients (n = 100) | Controls (n = 76) | p-values | |
|---|---|---|---|
Age (years) | |||
Mean ± SD | 41.7 ± 12.9 | 41.8 ± 17.0 | NS |
Range | 18.0–73.0 | 18.0–79.0 | |
Gender % (n) | |||
Female | 68.0 (68) | 73.7 (56) | NS |
Male | 32.0 (32) | 26.3 (20) | |
Chronic conditions % (n) | |||
Yes | 40.0 (40) | 10.5 (8) | ˂ 0.001 |
No | 60.0 (60) | 89.5 (68) | |
Allergy | 24.0 (24) | 18.4 (14) | |
Heart disease | 9.0 (9) | 2.6 (2) | |
Endocrinological disorders | 8.0 (8) | 0.0 (0) | |
Auto-immune disorders | 12.0 (12) | 2.6 (2) | |
Neurological disorders | 5.0 (5) | 2.6 (2) | |
Psychiatric disorders | 5.0 (5) | 0.0 (0) | |
Renal disease | 1.0 (1) | 0.0 (0) | |
Cancer (prostate) | 1.0 (1) | 0.0 (0) | |
Other | 8.0 (8) | 1.3 (1) | |
Number of medications | |||
Mean ± SD | 0.8 ± 1.0 | 0.4 ± 0.8 | ˂ 0.01 |
Tobacco use % (n) | |||
Smoking | 6.0 (6) | 2.6 (2) | NS |
Use of snuff | 11.0 (11) | 7.9 (6) | NS |
Time since COVID-19 diagnosis (months) | |||
Mean ± SD | 12.4 ± 7.2 | – | – |
Range | (2.0–39.0) | ||
Severity of COVID-19 disease | |||
Mild | 46.0 (46) | ||
Moderate | 52.0 (52) | – | – |
Severe | 1.0 (1) | ||
